Based on its molecular profile, this cancer is categorized as Luminal A, Luminal B, basal-like, human epidermal growth factor receptor 2 (HER2)-enriched, and normal-like, with triple-negative BC (TNBC) being the most aggressive subtype [3, 4]. This evidence concerns the gene ERBB2 and cancer.